Mi-Ran Yun

Title: Mi-Ran Yun: Innovator in Cancer Treatment

Introduction

Mi-Ran Yun is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of oncology, particularly in the treatment of non-small cell lung cancer. His innovative approach focuses on utilizing statin-based drugs to combat cancer that has developed resistance to traditional therapies.

Latest Patents

Mi-Ran Yun holds a patent for the "Use of statin-based drug for treatment of EML4-ALK-positive non-small cell lung cancer progressing on ALK inhibitor." This patent provides a pharmaceutical composition that exhibits therapeutic efficacy against EML4-ALK-positive non-small cell lung cancer. The invention includes a method for treating this type of cancer and offers guidance for drug selection to determine the appropriateness of administering a statin-based drug to patients.

Career Highlights

Throughout his career, Mi-Ran Yun has worked with reputable organizations, including Jeuk Co., Ltd. and Yonsei University. His experience in these institutions has allowed him to advance his research and contribute to the development of effective cancer treatments.

Collaborations

Mi-Ran Yun has collaborated with several professionals in his field, including Han Na Kang and Kyoung-Ho Pyo. These collaborations have enriched his research and have been instrumental in the progress of his innovative work.

Conclusion

Mi-Ran Yun's contributions to cancer treatment through his innovative use of statin-based drugs highlight his dedication to improving patient outcomes. His work continues to inspire advancements in the medical field.